SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Julius Caesar

PatientJulius Caesar
Date of birth1972-07-12
IdentifiersMRN HR-AC001-SYN; SSN (made up) 000-01-6022
Document date2026-09-15
AuthorLucius Fairbanks-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week review of levetiracetam, blood pressure, and the rhythm monitor. [S]

History of Present Illness

Julius Caesar returns four weeks after starting levetiracetam, atorvastatin, and aspirin. He has had no seizure, spell, or confused awakening. He was more irritable than usual in the first week, which has passed; he is not low in mood and has no thoughts of self-harm. His cold from last week has gone. He has no muscle aches, bruising, or bleeding. His home blood pressure readings over two weeks average 134/84 mmHg. The second rhythm monitor, removed yesterday, showed sinus rhythm throughout. The home sleep test showed no sleep apnea. He is not driving and has a riding companion at weekends. [S]

ElementDetail
SeizuresNone since levetiracetam was started
Side effectsIrritability in the first week, now gone
Home blood pressureAverage 134/84 mmHg over two weeks
Monitor and sleep testNo atrial fibrillation; no sleep apnea

Review of Systems

SystemResultFinding
ConstitutionalNegativeWell; cold resolved
MusculoskeletalNegativeNo muscle aches
NeurologicalNegativeNo spell, weakness, numbness, or speech change
PsychiatricNegativeIrritability settled; mood steady
HematologicNegativeNo bruising or bleeding

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth each morningOral route2026-08-04activeS
Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily500 mg twice daily, morning and eveningOral route2026-08-18activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtimeOral route2026-08-18activeS
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyOne tablet by mouth daily with foodOral route2026-08-18activeS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for fever or sore throat (no more than 3 g a day)One or two tablets every 6 hours as needed, at most 3 g a day, for up to a weekOral route2026-09-08 to 2026-09-14completedS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth each morningOral route2026-09-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-15Body height182cmS
2026-09-15Body weight75.6kgS
2026-09-15Body mass index (BMI) [Ratio]22.8kg/m2S
2026-09-15Systolic blood pressure136mm[Hg]S
2026-09-15Diastolic blood pressure84mm[Hg]S
2026-09-15Heart rate68/minS
2026-09-15Respiratory rate14/minS
2026-09-15Body temperature36.6CelS
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-09-15Total score [MoCA]28{score}S

Physical Exam

Vital signs recorded on 2026-09-15; see the Vital Signs section. [S]

SystemFinding
GeneralWell
CardiovascularRegular rhythm; blood pressure 136/84 mmHg
NeurologicalNo focal deficit; normal gait

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent transient episodes of collapse: six days ago a witnessed collapse with stiffening and jerking of both arms for about a minute, a bitten tongue, and about twenty minutes of confusion, after a rising strange feeling and dizziness; two briefer spells of staring and unresponsiveness in the past eighteen months; cause not yet known (seizure, convulsive syncope, or transient ischemic attack)resolvedconfirmed R56.9S — Synthetic presenting problem anchored to the documented accounts of falling attacks and fainting fits; it resolves when the cause is found.
Hypertension, stage 2: 152/94 and 148/92 mmHg today; told of high blood pressure about three years ago and never treatedactiveconfirmed I10S — Synthetic vascular risk factor; no blood pressure from his lifetime is known.
Hyperlipidemia: LDL 158 mg/dL, triglycerides 170 mg/dL, HDL 44 mg/dLactiveconfirmed E78.5S — Synthetic vascular risk factor; no lipid value from his lifetime is known.
Focal epilepsy with a structural vascular cause: focal impaired-awareness seizures with automatisms, one evolving to a bilateral tonic-clonic seizure, arising from a chronic left temporal cortical infarct, with left temporal sharp waves on EEGactiveconfirmed G40.209S — Synthetic modern diagnosis anchored to the documented falling attacks; the ILAE 2017 seizure types and a structural cause are chosen for teaching and make no claim about what he had.
Chronic left posterior temporal cortical infarct, not recognized before the seizures, with moderate small-vessel white matter disease and a non-stenotic left carotid plaque; no residual deficitactiveconfirmed I69.398S — Synthetic modern finding anchored to the retrospective cerebrovascular hypothesis; it makes no claim about his real brain.
Acute viral upper respiratory infection with low-grade fever and poor sleep, three weeks after starting levetiracetam; rapid COVID-19 and influenza tests negative; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness, chosen to teach cold-remedy choices with hypertension, aspirin, and an antiseizure medicine, and sleep loss as a seizure trigger; it echoes no documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure (target below 130/80 mmHg)Every visitCompleted today136/84 mmHg; home average 134/84 mmHg; amlodipine added
Self-managementHome blood pressure monitoringDaily while treatment is adjustedCompleted todayTwo weeks of stored readings reviewed
ImagingAmbulatory rhythm monitoring for atrial fibrillationAt least 30 days within six months of the eventCompleted todayMore than 40 days in all; no atrial fibrillation
ExaminationSleep apnea evaluationConsider after any strokeCompleted todayHome sleep test: apnea-hypopnea index 4 per hour; no sleep apnea
SurveyDepression screen (PHQ-9)At the first visit after the event, then periodicallyCompleted today4; item 9 scored 0
SurveyCognitive screen (MoCA)In the first year after a strokeCompleted today28 of 30
LaboratoryLipid panel after starting a statin4 to 12 weeks after startingDueAt the ten-week visit
Medication safetyStatin toleranceEvery visitCompleted todayNo muscle aches
Medication safetyAntithrombotic adherence and bleedingEvery visitCompleted todayAspirin taken daily; no bruising or bleeding
Medication safetyAntiseizure medicine: seizures, adherence, and side effectsEvery visitCompleted todayNo seizure; irritability in the first week only; no missed doses
ExaminationFall riskEvery visitCompleted todayNo falls
ExaminationWeight and BMIEvery visitCompleted today75.6 kg; BMI 22.8
Self-managementTobacco, alcohol, physical activity, and dietEvery visitCompleted todayDiet changes kept up; walking daily; alcohol unchanged
Self-managementSeizure safety and drivingEvery visitCompleted todayNot driving; riding only with a companion; seizure-free for four weeks

Goal progress:

Guideline basis: Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018); 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, hypertension, and hyperlipidemia monographs (2026)

Follow-up: Adult preventive visit in three weeks; ten-week chronic-care review with the lipid panel. Next scheduled visit 2026-10-06: adult preventive visit. [S]